TotalMarketCap

Krystal Biotech

KRYSNasdaq United StatesHealth CareBiotechnology: Biological Products (No Diagnostic Substances)

Market cap

$8.916 B

$300.86 -3.21%

Close of 6 Nov 2026

As of 6 Nov 2026, Krystal Biotech (KRYS) has a market capitalization of $8.92B. Market cap measures the value of outstanding equity at market prices; company totals combine applicable share classes. Prices and market caps come from Nasdaq, with financial fundamentals from SEC filings. See sources and calculation details.

Revenue

$389.1M

#2017 by revenue

Earnings

$204.8M

#990 by earnings

Shares outstanding

29,633,472

Latest filing cover page

P/E ratio

43.5

Cap ÷ net income

Biotechnology: Biological Products (No Diagnostic Substances), ranked by market cap

All 163 →
  1. #14QiagenQGEN$10.5B
  2. #15VaxcytePCVX$9.84B
  3. #16Krystal BiotechKRYS$8.92B
  4. #17ImmunityBioIBRX$8.48B
  5. #18Twist BioscienceTWST$7.95B

What if Krystal Biotech were worth as much as…

Open the what-if tool →

Gold $28.2T

$952,870.92

Per share 3,167× higher

Bitcoin $1.53T

$51,558.19

Per share 171× higher

Apple $5.02T

$169,260.71

Per share 563× higher

Or at a round number

$20.0B$50.0B$100.0B$200.0B

Where these numbers come from

Share counts and financials for Krystal Biotech are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Read the methodology.